In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested species

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 3, 1996, Pages 147-149

  Barrett, Mary S ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; IN VITRO STUDY; LACTOBACILLUS; LEGIONELLA; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0030199808     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00129-0     Document Type: Article

References (12)

1. Archer G, Auger P, Doern G, Ferraro MJ, Fuchs P, Jorgensen J, Low D, Murray P, Reller LB, Stratton C, Wennersten C, Moellering RC (1993) RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis 16: 223-226.
2. Chin NX, Neu HC (1991) Post-antibiotic effect of RP 59500 against Gram-positive bacteria compared to other agents. 31st ICAAC, Chicago, US: Abstract 899.
3. Etienne SD, Montay G, LeLibaux A, Frydman A, Garaud JJ (1992) A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behavior of RP 59500. J Antimicrob Chemother 30(Suppl A):123-131.
4. Freeman C, Robinson A, Cooper B, Mazens-Sullivan M, Quintilliani R, Nightingale C (1995) In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis 21:47-50.
5. Goto S, Miyazaki S, Kaneko Y (1992) The in vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic against Gram-positive bacteria. J Antimicrob Chemother 30(Suppl A):25-28.
6. Johnson CC, Slavoski L, Schwartz M, May P, Pitsakis PG, Shur AL, Levison ME (1995) In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci. Diagn Microbiol Infect Dis 21;169-173.
7. National Committee for Clinical Laboratory Standards (NCCLS). (1993a) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. Villanova, PA: NCCLS.
8. National Committee for Clinical Laboratory Standards (NCCLS). (1993b) Methods for antimicrobial susceptibility testing of an aerobic bacteria, 3rd ed. Approved standard M11-A3. Villanova, PA: NCCLS.
9. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance standards for antimicrobial susceptibility testing. Sixth Information Supplement M100-S6. Villanova, PA: NCCLS.
10. Neu HC, Chin N, Gu J. (1992) The in vitro activity of new streptogramins, RP 59500, RP 57669, and RP 54476, alone and in combination. J Antimicrob Chemother 30(Suppl A):83-94.
11. Renaudin H, Boussens B, Bebear C (1991) In vitro activity of RP 59500 against mycoplasma. 31st ICAAC, Chicago, US: Abstract 893.
12. Soussy CJ, Acar JF, Cluzel R, Courvalin P, Duval J, Fleurette J, Megraud, Meyran M, Thabaut A (1992) A collaborative study of the in vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. J Antimicrob Chemother 30(Suppl A):53-58.